olaratumab
0 sources
olaratumab
Summary
olaratumab is a type of chemical entity[1]. olaratumab has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[2]
Key Facts
- olaratumab's instance of is recorded as type of chemical entity[3].
- olaratumab's physically interacts with is recorded as Platelet derived growth factor receptor alpha[4].
- olaratumab's manufacturer is recorded as Eli Lilly and Company[5].
- olaratumab's chemical formula is recorded as C₆₅₅₄H₁₀₀₇₆N₁₇₃₆O₂₀₄₈S₄₀[6].
- olaratumab is a type of chemical compound[7].
- olaratumab is used for medication[8].
- olaratumab's side effect is recorded as neutropenia[9].
- olaratumab's medical condition treated is recorded as soft-tissue sarcoma[10].
- olaratumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'olaratumab'}[11].
- olaratumab's subject has role is recorded as antineoplastic[12].
- olaratumab's subject has role is recorded as monoclonal antibody[13].
- olaratumab's active ingredient in is recorded as Lartruvo[14].
- olaratumab's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category E[15].
Why It Matters
olaratumab has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[2] olaratumab is known by 4 alternative names across languages and contexts.[16]